Gerald B. Pier
38Patents
12h-index
21Co-inventors
81Inventor score
Filing activity: Dec 10, 1979 → Feb 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5055455A | Capsular polysaccharide adhesin antigen, preparation, purification and use | Emerging Cross-Sectional Technologies | 47 | Expired |
| US4285936A | Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa | Human Necessities | 39 | Expired |
| US6245735A | Methods and products for treating pseudomonas infection | Emerging Cross-Sectional Technologies | 37 | Expired |
| US4578458A | Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa | Emerging Cross-Sectional Technologies | 36 | Expired |
| US7252828B2 | Polysaccharide vaccine for staphylococcal infections | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5980910A | Capsular polysaccharide adhesion antigen preparation, purification and use | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5989542A | Capsular polysaccharides from enterococci | Human Necessities | 26 | Expired |
| US6399066B1 | Capsular polysaccharide adhesin antigen, preparation, purification and use | Emerging Cross-Sectional Technologies | 24 | Expired |
| US8080394B2 | Method for determining predisposition to pulmonary infection | Chemistry; Metallurgy | 23 | Active |
| US6743431B2 | Capsular polysaccharide adhesin antigen, preparation, purification and use | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7786255B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 17 | Active |
| US6962813B2 | P. aeruginosa mucoid exopolysaccharide specific binding peptides | Chemistry; Metallurgy | 13 | Expired |
| US7723087B2 | Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof | Chemistry; Metallurgy | 12 | Expired |
| US8492364B2 | Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides | Emerging Cross-Sectional Technologies | 11 | Active |
| US8663654B2 | Polysaccharide vaccine for staphylococcal infections | Emerging Cross-Sectional Technologies | 10 | Active |
| US8461319B2 | Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US8084595B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US8252894B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US8435515B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US7015007B2 | Capsular polysaccharide adhesin antigen, preparation, purification and use | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8410249B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US8350017B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US8912314B2 | Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US6825178B1 | Methods and products for treating pseudomonas infection | Emerging Cross-Sectional Technologies | 7 | Expired |
| US9474806B2 | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides | Emerging Cross-Sectional Technologies | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.